IP Verse

Aluminium Compounds For Use In Therapeutics And Vaccines - EP3106176

The patent EP3106176 was granted to Valneva Austria on Oct 11, 2017. The application was originally filed on Dec 6, 2012 under application number EP16183076A. The patent is currently recorded with a legal status of "Revoked".

EP3106176

VALNEVA AUSTRIA
Application Number
EP16183076A
Filing Date
Dec 6, 2012
Status
Revoked
Mar 24, 2022
Grant Date
Oct 11, 2017
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

SANOFI PASTEURJul 10, 2018CABINET BEAU DE LOMENIE -

Patent Citations (21) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONCN101734698
DESCRIPTIONEP0497524
DESCRIPTIONEP0497525
DESCRIPTIONUS4057685
DESCRIPTIONUS4459286
DESCRIPTIONUS4663160
DESCRIPTIONUS4673574
DESCRIPTIONUS4695624
DESCRIPTIONUS4761283
DESCRIPTIONUS4761372
DESCRIPTIONUS4808700
DESCRIPTIONUS4882317
DESCRIPTIONUS4965338
DESCRIPTIONUS5308835
DESCRIPTIONWO0010599
DESCRIPTIONWO02064162
DESCRIPTIONWO9814401
DESCRIPTIONWO9842375
OPPOSITIONWO2013083726
SEARCHUS2005158334
SEARCHWO2009158284

Non-Patent Literature (NPL) Citations (45) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- ALIPAZAGA MV; MORENO RGM; COICHEV N, "Synergistic effect of Ni(II) and Co(II) ions on the sulphite induced autoxidation of Cu(II)/tetraglycine complex", DALTON TRANS, (2004), vol. 13, pages 2036 - 2040-
DESCRIPTION- BERGLUND J; FRONAEUS S; ELDING LI., "Kinetics and mechanism for manganese-catalyzed oxidation of sulfur(IV) by oxygen in aqueous solution", INORG CHEM, (1993), vol. 32, pages 4527 - 4538-
DESCRIPTION- BURNOUF T, VOX SANG, (1991), vol. 60, pages 8 - 15-
DESCRIPTION- EXLEY, C, TRENDS IN IMMUNOL, (2010), vol. 31, pages 103 - 109-
DESCRIPTION- GEVER ET AL., MED. MICROBIOL. IMMUNOL, (1979), vol. 165, pages 171 - 288-
DESCRIPTION- HUIE R.E.; NETA P, "One-electron redox reaction in aqueous solutions of sulphite with hydroquinone and other hydroxyphenols", J. PHYS. CHEM., (1985), vol. 89, no. 18, pages 3918 - 3921-
DESCRIPTION- ITO, KIMIKO; KAWANASHI, SHOSUKE, "Site-specific fragmentation and modification of Albumin by sulphite in presence of metal ions or peroxidase/HzOz: Role of Sulphate radical", BIOCHEM AND BIOPHYS RES COMM., (1991), vol. 176, pages 1306 - 1312-
DESCRIPTION- JONES ET AL., AN. ACAD. BRAS. CIENC, (2005), vol. 77, no. 2, pages 293 - 324-
DESCRIPTION- KALINA RANGUELOVA; MARCELO G. BONINI; RONALD P. MASON, "Bi)sulphite Oxidation by Copper,Zinc-Superoxide Dismutase: Sulphite- Derived, Radical-Initiated Protein Radical Formation", ENVIRONMENTAL HEALTH PERSPECTIVES, (2010), vol. 118, no. 7, pages 970 - 975-
DESCRIPTION- LAMBETH D.O.; PALMER G., "The kinetics and mechanism of reduction of electron transfer proteins and other compounds of biological interest by dithionite", J.BIOCHEM. CHEM, (1973), vol. 248, pages 6095 - 6103-
DESCRIPTION- LIMA S; BONIFACIO RL; AZZELLINI GC; COICHEV N, "Ruthenium(II) tris(bipyridyl) ion as a luminescent probe for oxygen uptake on the catalyzed oxidation of HS0", TALANTA, (2002), vol. 56, pages 547 - 556-
DESCRIPTION- LIN C.-W; WU W.-C, J VIROL., (2003), vol. 77, no. 4, pages 2600 - 6-
DESCRIPTION- LIN C.-W; WU W.-C., J VIROL., (2003), vol. 77, no. 4, pages 2600 - 6-
DESCRIPTION- LINDBLAD, EB, IMMUNOL. AND CELL BIOL., (2004), vol. 82, pages 497 - 505-
DESCRIPTION- NETA P; HUIE R.E, "Free Radical Chemistry of Sulphite", ENVIRONMENTAL HEALTH PERSPECTIVES, (1985), vol. 64, pages 209 - 217-
DESCRIPTION- ROBBINS ET AL., JAMA, (1996), vol. 276, no. 14, pages 1181 - 5-
DESCRIPTION- SHI X, "Generation of SO and OH radicals in SO reactions with inorganic environmental pollutants and its implications to SO toxicity", J INORG BIOCHEM, (1994), vol. 56, no. 3, pages 155 - 165-
DESCRIPTION- LI S; SCHONEICH C; BORCHARDT RT., "Chemical instability of protein pharmaceuticals: Mechanisms of oxidation and strategies for stabilization", BIOTECHNOL BIOENG, (19951205), vol. 48, no. 5, doi:doi:10.1002/bit.260480511, pages 490 - 500, XP055040145
DESCRIPTION- STADTMAN ER, "Metal ion-catalyzed oxidation of proteins: biochemical mechanism and biological consequences", FREE RADIC BIOL MED., (1990), vol. 9, no. 4, doi:doi:10.1016/0891-5849(90)90006-5, pages 315 - 25, XP023548593
DESCRIPTION- ARUNEE WITTAYANUKULLUK; DONGPING JIANG; FRED E. REGNIER; STANLEY L. HEM, "Effect of microenvironment pH of aluminum hydroxide adjuvant on the chemical stability of adsorbed antigen", VACCINE, (2004), vol. 22, doi:doi:10.1016/j.vaccine.2003.09.037, pages 1172 - 1176, XP004493380
DESCRIPTION- MAYO JC; TAN DX; SAINZ RM; NATARAJAN M; LOPEZ-BURILLO S; REITER RJ, "Protection against oxidative protein damage induced by metal-catalyzed reaction or alkylperoxyl radicals: comparative effects of melatonin and other antioxidants", BIOCHIM BIOPHYS ACTA, (20030317), vol. 1620, no. 1-3, doi:doi:10.1016/S0304-4165(02)00527-5, pages 139 - 50, XP004410890
DESCRIPTION- BRANDT C; ELDING LI., "Role of chromium and vanadium in the atmospheric oxidation of sulfur (IV", ATMOS ENVIRON, (1998), vol. 32, no. 4, doi:doi:10.1016/S1352-2310(97)00331-2, pages 797 - 800, XP004890864
OPPOSITION- "ALUMINIUM (CHLORURE D') HEXAHYDRATE", PHARMACOPEE EUROPEENNE 9.0, (20170100), pages 1806 - 1807, XP055605074-
OPPOSITION- "Aluminium hydroxide, hydrated, for adsorption", EUROPEAN PHARMACOPOEIA 6.1, (20080401), pages 3395 - 3396, XP055605179-
OPPOSITION- Anonymous, "Assessment report for Ixiaro Common Name: Japanese Encephalitis Vaccine (inactivated, adsorbed) Procedure No. EMEA/H/C/000963", EMA, (20090000), pages 1 - 50, XP055605067-
OPPOSITION- "Assessment report for IXIARO Review under Article 20 of Regulation (EC) No 726/ 2004 INN: Japanese encephalitis virus strain SA 14-14- 2 Procedure number: EMEA/H/C/963/A-20/0029", EMA, (20120525), pages 1 - 8, XP055605071-
OPPOSITION- C. SCOTT, "Formulation Development - Making the Medicine", BioProcess International, (20060300), pages 42 - 56, XP055605197-
OPPOSITION- "Denomination du medicament AVAXIM 80 U PEDIATRIQUE, suspension injectable en recipient multidose vaccin inactive de l'hepatite A adsorbe", ANSM, (20100121), page 6pp, URL: http://agence-prd.ansm.sante.fr/php/ecodex/notice/NO171574.htm, XP055605192-
OPPOSITION- "DULTAVAX, suspension injectable en seringue préremplie. Vaccin diphtérique, tétanique et poliomyélitique (inactivé), (adsorbé)", ansm, (20101112), page 7pp, XP055604556-
OPPOSITION- "ICP-MS", Université de Manchester, (20110823), page 7pp, Williamson Research Centre wiki, URL: http://wiki.manchester.ac.uk/wrc/index.php/ICP-MS, XP556050500-
OPPOSITION- "IXIARO suspension injectableVaccin de l'encephalite japonaise (inactivé,adsorbé)", medikamio, (20100300), XP055605220-
OPPOSITION- "Osmium", Inorganic Ventures, (20130101), URL: www.inorqanicventures.com/element/osmium, XP055605207-
OPPOSITION- "Plus simple. Plus rapide. Plus precis. Passez a un niveau superieur d'ICP-MS. ICP-MS Agilent Serie 7500", Agilent Technologies, (20070000), pages 1 - 12, XP055605038-
OPPOSITION- rapport d'analyse du lot FA 353455 de gel d'hydroxyde d'aluminium hydraté-
OPPOSITION- REEMERS et al., "Reduced immune reaction prevents immunopathology after challenge with avian influenza virus: A transcriptomics analysis of adjuvanted vaccines", Vaccine, (20100000), vol. 28, pages 6351 - 6360, XP027211946-
OPPOSITION- "Résumé des caractéristiques du produit", l'ANSM, (20101112), DULTAVAX®, URL: http://agence- prd.ansm.sante.fr/php/ecodex/rcp/R0184995.htm#Rcp_2_Compo QualitQuanti_1, XP055604565-
OPPOSITION- "Vaccine Recall Ixiaro - Japanese Encephalitis", (20110614), page 2pp, Travel Clinic Blog, URL: http://www.travelclinic.ltd.uk/blog/post/2011/06/14/VACCINE-RECALL-Ixiaro-Japa..., XP055605060-
OPPOSITION- A. SOYSAL et al., "Interchangeability of a hepatitis A vaccine second dose: Avaxim 80 following a first dose of Vaqta 25 or Havrix 720 in children in Turkey", Eur. J. Pedatr., (20070000), vol. 166, pages 533 - 539, XP019517692
OPPOSITION- MIYAKI et al., "Production of H5N1 (NIBRG-14) inactivated whole virus and split virion influenza vaccines and analysis of immunogenicity in mice using différent adjuvant formulations", Vaccine, (20100000), vol. 28, doi:doi:10.1016/j.vaccine.2010.01.044, pages 2505 - 2509, XP026944260
SEARCH- ANONYMOUS, "Rehydragel Adjuvants. Product profile", (2008), pages 1 - 2, General Chemical, URL: http://www.generalchemical.com/assets/pdf/Rehydragel_Adjuvants_Product_Profile.pdf, (20121008), XP002684848 [A] 1-15 * the whole document *-
SEARCH- SRIVASTAVA A K ET AL, "A purified inactivated Japanese encephalitis virus vaccine made in vero cells", VACCINE, ELSEVIER LTD, GB, vol. 19, no. 31, ISSN 0264-410X, (20010814), pages 4557 - 4565, (20010814), XP027321987 [A] 1-15 * abstract * * page 4560, column l, paragraph 2 * * page 4561, column r, paragraph l - page 4562, column l, paragraph 1 * * page 4563, column r, paragraph l; table 5 * * page 4564, column r, paragraph l *-
SEARCH- LI S; SCHONEICH C; BORCHARDT RT, "Chemical instability of protein pharmaceuticals: Mechanisms of oxidation and strategies for stabilization.", BIOTECHNOL BIOENG., (19951205), vol. 48, no. 5, pages 490 - 500, XP055040145 [AD] 1-15 * abstract * * page 491, column l, paragraph 2 - paragraph 3 * * page 497, column r, paragraph 3 *
SEARCH- TIA ESTEY ET AL, "Evaluation of chemical degradation of a trivalent recombinant protein vaccine against botulinum neurotoxin by LysC peptide mapping and MALDI-TOF mass spectrometry", JOURNAL OF PHARMACEUTICAL SCIENCES, (20090901), vol. 98, no. 9, doi:10.1002/jps.21543, ISSN 0022-3549, pages 2994 - 3012, XP055040203 [A] 1-15 * abstract * * page 2995, column l, paragraph 1 - column r, paragraph 1 * * page 2996, column r, paragraph 2 - page 2997, column l, paragraph 4 *
SEARCH- ROBERT SCHLEGL ET AL, "Influence of elemental impurities in aluminum hydroxide adjuvant on the stability of inactivated Japanese Encephalitis vaccine, IXIARO", VACCINE, GB, (20151101), vol. 33, no. 44, doi:10.1016/j.vaccine.2015.05.103, ISSN 0264-410X, pages 5989 - 5996, XP055315021
SEARCH- LINDBLAD, EB, "Special feature. Aluminium compounds for use in vaccines", IMMUNOL. AND CELL BIOL., (2004), vol. 82, pages 497 - 505, XP008151421 [AD] 1-15 * the whole document *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents